[Expectations in the clinical application of human-recombinant cytokines. 2) Clinical trials of IL-2].
D000970:Antineoplastic Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D006801:Humans; D007116:Immunization, Passive; D007262:Infusions, Intravenous; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000637:transplantation; D008222:Lymphokines / Q000008:administration & dosage; D009369:Neoplasms / Q000628:therapy*; D011995:Recombination, Genetic
D000970:Antineoplastic Agents; D007376:Interleukin-2; D008222:Lymphokines